Pulmonary Embolism (PE) - Nursing Case Study

Pathophysiology

• Primary mechanism: Thrombus formation typically originates in the deep veins of the lower extremities, detaching and traveling through the venous system to the pulmonary vasculature, causing an obstruction in a pulmonary artery. This impedes blood flow and can lead to ventilation-perfusion mismatch, resulting in hypoxemia.

• Secondary mechanism: The obstruction increases pulmonary vascular resistance, leading to elevated right ventricular afterload. This can cause right ventricular dilation and dysfunction, potentially progressing to right-sided heart failure if untreated.

• Key complication: The sudden increase in pulmonary artery pressure and subsequent cardiac strain can result in decreased cardiac output and systemic hypotension, posing a significant risk of circulatory collapse and shock, which are life-threatening without prompt intervention.

Patient Profile

Demographics:

52-year-old female, office manager

History:

• Key past medical history: History of deep vein thrombosis, hypertension, type 2 diabetes, and recent surgery for hip replacement

• Current medications: Warfarin, Metformin, Lisinopril, and Insulin

• Allergies: Penicillin and shellfish

Current Presentation:

• Chief complaint: Sudden onset of severe shortness of breath and chest pain

• Key symptoms: Difficulty breathing, sharp chest pain worsened by deep breaths, rapid heart rate, dizziness, and sweating

• Vital signs: Blood pressure 85/60 mmHg, heart rate 130 bpm, respiratory rate 30 breaths per minute, oxygen saturation 82% on room air, temperature 37.5°C (99.5°F)

Section 1

Initial Assessment Findings:

Upon the patient's arrival to the emergency department, an immediate assessment is conducted. The patient appears anxious and diaphoretic, with pronounced use of accessory muscles for respiration. Lung auscultation reveals diminished breath sounds bilaterally and crackles in the lower lung fields, suggesting pulmonary congestion. Heart sounds are tachycardic with a regular rhythm, and jugular venous distension is noted, indicative of right-sided heart strain. Peripheral extremities are cool and clammy to the touch, reflecting poor perfusion due to systemic hypotension. The patient's skin is pale, and capillary refill is sluggish, further evidencing compromised cardiac output.

A stat arterial blood gas (ABG) analysis shows severe hypoxemia with a PaO2 of 55 mmHg and respiratory alkalosis with a pH of 7.48 and PaCO2 of 30 mmHg, indicating hyperventilation due to the distress. Initial laboratory tests return with an elevated D-dimer level, supporting the suspicion of thromboembolic activity. An urgent computed tomography pulmonary angiography (CTPA) is ordered, which confirms a large saddle embolus obstructing both the left and right main pulmonary arteries. The echocardiogram reveals right ventricular dilation and moderate tricuspid regurgitation, consistent with acute cor pulmonale.

These findings confirm the diagnosis of a massive pulmonary embolism with significant hemodynamic compromise. The patient is at high risk for cardiovascular collapse, necessitating immediate intervention. The clinical team initiates high-flow oxygen therapy to improve oxygenation and prepares for possible thrombolytic therapy, weighing the benefits against the risk of bleeding due to the patient's recent surgery and current anticoagulation therapy with warfarin. The situation demands continuous monitoring and reassessment, as the patient's condition remains critical with potential for rapid deterioration.

Section 2

As the clinical team deliberates the risks and benefits of thrombolytic therapy, the patient's condition takes a sudden turn. The patient begins to exhibit signs of worsening respiratory distress, with an increased respiratory rate now exceeding 35 breaths per minute and a drop in oxygen saturation to 82% even with high-flow oxygen supplementation. The patient's anxiety escalates, and they report a sharp, pleuritic chest pain, further exacerbating their respiratory effort. A rapid assessment reveals a significant drop in blood pressure to 80/50 mmHg, indicating a further decline in hemodynamic stability.

In response to the critical change in status, the team initiates norepinephrine infusion to support blood pressure and improve perfusion. Despite this, the patient remains hypotensive, and urine output decreases to less than 20 mL/hr, raising concerns about impending renal compromise. Given the high risk of cardiovascular collapse and the life-threatening nature of the saddle embolus, the decision is made to proceed with systemic thrombolysis using alteplase, alongside continued mechanical ventilation support.

Meanwhile, repeat laboratory tests reveal a further increase in lactate levels to 5.2 mmol/L, indicating worsening tissue hypoxia. The patient's INR is noted to be 3.5, reflecting the challenging balance between anticoagulation for thromboembolic management and the risk of bleeding complications. As the alteplase infusion commences, the clinical team remains vigilant for signs of bleeding, particularly intracranial hemorrhage, while closely monitoring the patient’s neurological status and vital signs. This high-stakes scenario demands exceptional clinical acumen to navigate the complex interplay of interventions and evolving complications, all while maintaining a focus on the ultimate goal of stabilizing the patient’s condition.

Section 3

As the alteplase infusion progresses, the clinical team meticulously monitors the patient for any adverse reactions, remaining acutely aware of the potential for bleeding complications. Within the first hour, the patient's respiratory rate begins to stabilize, decreasing to 28 breaths per minute, and oxygen saturation improves marginally to 86% with continued high-flow oxygen. However, blood pressure remains tenuously low at 85/55 mmHg despite norepinephrine support, and the team considers the possibility of incorporating additional vasopressors if needed. The presence of jugular venous distention and distant heart sounds raises concerns about potential cardiac tamponade as a new complication, warranting immediate attention.

Simultaneously, a follow-up CT angiography is conducted to assess the effectiveness of the thrombolytic therapy. The imaging reveals partial resolution of the massive saddle embolus, yet significant perfusion deficits persist, particularly affecting the right lower lobe. This finding correlates with the patient's continued hypoxemia and provides insight into the persistent respiratory distress. The team also notes mild right ventricular dilatation, suggesting ongoing strain on the heart, which may account for the hemodynamic instability.

In light of these developments, a comprehensive reassessment of the patient's fluid status and renal function is undertaken. Serum creatinine has risen to 2.1 mg/dL, confirming acute kidney injury likely secondary to both hypotension and hypoperfusion. The decision is made to cautiously administer isotonic fluids, balancing the need to improve renal perfusion against the risk of exacerbating cardiac preload. The team remains vigilant in their monitoring, recognizing that any further deterioration could necessitate more invasive interventions, such as extracorporeal membrane oxygenation (ECMO), to support both cardiac and respiratory function. This critical juncture in care emphasizes the need for precise clinical judgment and adaptability in the face of rapidly evolving challenges.

Section 4

As the clinical team continues to navigate the complexities of the patient's condition, a sudden change in status necessitates immediate action. The patient experiences an abrupt drop in consciousness level, becoming unresponsive to verbal stimuli and only minimally responsive to painful stimuli. This altered mental status raises significant concerns, prompting an urgent reevaluation of the patient's neurological status and potential causes. The team quickly assesses for signs of intracranial hemorrhage, a known risk associated with thrombolytic therapy, given the recent administration of alteplase. Neurological assessment reveals unequal pupils, sluggish reaction to light, and a new right-sided hemiparesis, heightening suspicion of a cerebrovascular event.

Simultaneously, a portable head CT scan is expedited to confirm the presence of any intracranial bleeding or ischemic stroke. While awaiting the imaging results, the team carefully considers the implications of these findings on the ongoing management plan. The potential for a thromboembolic event in the cerebral circulation or a hemorrhagic complication necessitates a reevaluation of anticoagulation strategy and the consideration of reversing agents if bleeding is confirmed. Additionally, the team reviews the patient's coagulation profile, noting a significant elevation in INR and prolonged aPTT, suggesting a heightened risk of bleeding complications that could further complicate the clinical picture.

In response to these new developments, the critical care team intensifies their monitoring efforts, ensuring continuous neurovascular assessments and maintaining readiness for potential neurosurgical intervention if indicated by the CT findings. The evolving scenario underscores the importance of multidisciplinary collaboration, as neurologists, cardiologists, and intensivists work in concert to tailor a dynamic care plan that addresses both the acute neurological compromise and ongoing cardiopulmonary instability. This pivotal moment in the patient's journey demands astute clinical reasoning and prompt decision-making to mitigate further deterioration and optimize outcomes.

Section 5

As the clinical team awaits the results of the head CT scan, a nurse notices further deterioration in the patient's vital signs. The patient's blood pressure starts to drop, recorded at 85/50 mmHg, with a heart rate climbing to 130 beats per minute. Oxygen saturation levels have also decreased to 88% on high-flow oxygen, indicating worsening respiratory compromise. These changes suggest a potential exacerbation of the underlying pulmonary embolism, possibly due to increased pulmonary vascular resistance or recurrent embolic events. Concerns about hypovolemic shock due to potential intracranial hemorrhage or distributive shock secondary to systemic complications further complicate the clinical picture.

The head CT scan results come back, confirming the presence of a left-sided intracerebral hemorrhage, which correlates with the patient's neurological deficits and altered mental status. The hemorrhage's location and size raise immediate questions about the viability of reversing the effects of thrombolytic and anticoagulant therapies. Given the elevated INR of 3.2 and prolonged aPTT, the risk of continued bleeding is significant. The neurology team recommends administering prothrombin complex concentrates and vitamin K to reverse coagulopathy while preparing for possible neurosurgical intervention based on further clinical assessment.

In parallel, the critical care team initiates cautious fluid resuscitation to support hemodynamics, balancing the need to prevent further cerebral edema. The interdisciplinary team, including intensivists, neurologists, and cardiologists, reconvenes to refine the patient's management plan, acknowledging the dual threat of cardiopulmonary instability and neurological deterioration. This crucial juncture requires precision in balancing aggressive treatment of the pulmonary embolism with emergent management of intracranial bleeding, illustrating the complexity and high stakes of critical care nursing in acute, multi-system failure scenarios.